Polymorphism of FcγRIIIA-158F/V and promotion region of 1L-10 genes in systemic lupus erythematosus in Kazakhs

Terapevticheskii Arkhiv

Volumn 75, Issue 5, 2003, Pages 36-41

  Guseva, I A ^a   Omarbekova, Zh E ^a   Myakotkin, V A ^a  

^a NONE

Author keywords

Fc receptor; Genetic polymorphism; IL 10; Systemic lupus erythematosus

Indexed keywords

FC RECEPTOR; INTERLEUKIN 10; MARKER;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; KAZAKHSTAN; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION; PROMOTER REGION; SYSTEMIC LUPUS ERYTHEMATOSUS; TECHNIQUE; ADULT; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; IMMUNOLOGY; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; INTERLEUKIN-10; KAZAKHSTAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, IGG; RISK FACTORS;

EID: 0642369670     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Moutz J. D., Wu J., Cheng J., Zhou T. Arthr. and Rheum. 1994; 37: 1415-1420.
2. Levy Y., Brouet J. C. Interleukin-10 prevents spontaneous death of germinal center Bcells by induction of the bcl-2 protein. J. Clin. Invest. 1994; 93: 424-428.
3. Wu J., Edberg J. C., Redecha P. B. et al. A novel polymorphism of FcγRIIIA (CD 16) alter receptor function and predisposes to autoimmune desease. Ibid. 1997; 100(5): 1059-1070.
4. Lawrence J. S., Martins C. L., Drake G. L. A family survey of lupus erythematosus: 1. Heritability. J. Rheumatol. 1987; 14: 913-921.
5. Lindqvist A.-K., Alarcon-Riquelme M. E. The genetic of systemic lupus erythematosus. Scand. J. Rheumatol. 1999; 50: 562-571.
6. Tan F. K., Arnett F. C. The genetics of lupus. Curr. Opin. Rheumatol. 1998; 10: 399-408.
7. Deapen D., Escalanta A., Weinrib L. et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthr. and Rheum. 1992; 35: 311-317.
8. Hochberg M. C. The application of genetic epidemiology to systemic lupus erythematosus. J. Rheumatol. 1987; 14: 867-869.
9. Jarvinen P., Karpio J., Makitalo R. et al. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J. Intern. Med. 1992; 231: 67-72.
10. Dunkley H., Gatenby P., Hawkins B. et al. Dificienty of C4A in a genetic determinant of systemic lupus erythematosus in three ethnic groups. J. Immunogene 1987; 14: 209-218.
11. Fielder A. H., Walport M. J., Batchelor J. R. et al. Family study of the major histocompatibility complex in patien with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br. Med. J. 1983; 286: 425-428.
12. Hartung K., Bour M., Coldewey R. et al. Major histocompatibility complex haplotypes and comlement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J. Clin. Invest. 1992; 9: 1346-1351.
13. Howard P. F., Hochberg M. C., Arnett F. C., McLean R. H. Relationship between C4 null genes, HLA D region antigens and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am. J. Med. 1986; 81: 187-193.
14. Bredius R. G. M., Fijen C. A. P., de Haas M. et al. Role of the neutrophil FcγRIIIA (CD32) and the FcγRIIIB (CD 16) polymorphic form in phagocytosis of human IgG1-IgG3-opsonized bacteria and erythrocytes. Immunology 1994; 83: 624-630.
15. Hibbs M. L., Tolvanen M., Carpen O. Membrane-proximal Iglike domain of FcγRIII(CD16) contains residues critical for ligand binding. J. Immunol. 1994; 152: 4466-4474.
16. Koene H. R., de Haas M. FcγRIII-158 V/F polimorphism influences the bindind of IgG by NK cell FcγRIIIA, independly of the FcγRIIIA-48 L/R/H phenotype. Blood 1997; 90: 1109-1114.
17. Ding L., Linsley P. S., Germain R. N. et al. I1-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993; 151: 1224-1234.
18. te Velde A. A., De Waal Malefijt R., Huijbens R. J., de Vries J. E. IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity: distinct regulation of antibody-dependent cellular cytotoxity by IFN-γ, IL-4 and IL-10. Ibid. 1992; 149: 4048-4057.
19. Itoh K., Hirohata S. The role of IL-10 in human B cell activation, proliferation and differentiation. Ibid. 1995; 154: 4341-4540.
20. Llorente L., Zou W., Levy Y. et al. Role of interleukin-10 in the B lymphocytes hiperactivity and human systemic lupus erythematosus. J. Exp. Med. 1995; 181: 839-844.
21. Llorente L., Richaud-Patin Y., Couderc J. et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthr. and Rheum. 1997; 40: 1429-1435.
22. Koene H. R., Kleijer V., Sullivan K. E. et al. The FcγRIIIA-158 F allele is a risk factor systemic lupus erythematosus. Ibid. 1998; 41: 1813-1818.
23. Salmon J. E., Ng S., You D. H. et al. Altered distribution of Fc gamma receptor IIIA alleles in a cohort of Korean patients with systemic lupus erythematosus. Ibid. 1999; 42: 818-819.
24. Seligman V. A., Suarez. Ch., Lum R. et al. The Fcγ receptor IIIA-158F allele is a major risk factor the development of lupus nephritis among caucasians but not non-caucasians. Ibid. 2001; 44: 618-625.
25. Zuniga R., Ng S., Peterson M. G. E. et al. Low binding alleles of Fcγ receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in hispanic patients. Ibid. 2001; 42: 361-367.
26. Dijstelbloem H. M., Marc B., Fijnheer R. et al. Fcγ receptor polymorphism in systemic lupus erythematosus. Assotiation with disease and in vivo clearance of immune complexes. Ibid. 2000; 43: 2793-2800.
27. Manger K., Repp R., Jansen M. et al. Fcγ receptor IIA, IIIA and IIIB polymorphism in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann. Rheum. Dis. 2002; (9): 786-792.
28. Hatta J., Tsuchiya N., Ohashi J. Association of Fc gamma receptor IIIB, but not of Fc famma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immunol. 1999; 1: 53-60.
29. Oh M., Petri M. A., Kim N. A., Sullivan K. E. Frequency of the Fc gamma RIIIA158 F allele in African American patients with systemic lupus erythematosus. J. Rheumatol. 1999; 26: 1486-1489.
30. Eskdale J., Wordsworth P., Bowman S. et al. Assosiation between polymorphisms at the human 11-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635-639.
31. Lazarus M., Hajeer A. H., Turner D. et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol. 1997; 24: 2273-2275.
32. Mok Ch., Lanchbury J. S., Chan D. W., Lau C. S. Interleukin-10 promoter polymorphism in southern chinese patients with systemic lupus erythematosus. Arthr. and Rheum. 1998; 41: 1090-1095.
33. D'Alfonso S., Rampi M., Bocchio D. et al. Systemic lupus erythematosus candidate genes in the Italian population. Evidence for a significant assosiation with interleukin 10. Ibid. 2000; 43: 120-128.
34. Ishida H., Muchamuel T., Sakaguchi S. et al. Continious administration of antiinterleukin 10 antibodies delays the onset of autoimminity in NZB/W F1 mice. J. Exp. Med. 1994; 179: 305-310.
35. Rousset F., Garcia E., Defrance T., Perrone C. Interleukin 10 is a potent growt and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 1992; 89: 1890-1893.
36. Mehrian R., Quismorio F. P., Strassmann G., Stimmler M. M. Synergistic effect between 11-10 and Bcl-2 genotypes in determining susceptibilty to systemic lupus erythematosus. Arthr. and Rheum. 1998; 41: 596-602.
37. Tan E. M., Cohen A. S., Fries J. F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Ibid. 1982; 25: 1271-1277.
38. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human 11-10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-128.
39. Tsao B. P., Cantor R. M., Kalunian K. C. et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest. 1997; 99: 725-731.